Hexal Korea Launches Marketing Activities for Ethical Generics

Hexal Korea, a local subsidiary of Germany's Hexal AG, has recently launched its marketing activities by introducing four pharmaceutical generic products in the domestic market SimvaHexal, LisiHexal, EnaHexal, and Fluneurin.

SimvaHexal (active ingredient: simvastatin) is for treatment of hyperlipidemia (elevation of lipids in the bloodstream), and both LisiHexal (lisinopril) and EnaHexal (e...